EQT Partners is preparing to divest its 40% stake in CitiusTech, aiming to realize nearly $1 billion from the exit underscoring strong investor confidence in the global healthcare-IT and analytics sector.
Glimpse:
The deal would value CitiusTech at around US$ 2.2–2.4 billion, roughly 18-20 times its projected FY26 EBITDA of ~$120 million. This marks a significant private-equity exit from one of the largest global players in healthcare data, analytics, and digital-health consulting.
EQT Partners which acquired a controlling stake in CitiusTech in 2019 is now working with advisors to sell its entire ~40% shareholding in the healthcare-IT firm. The planned exit comes after a six-year investment period, during which CitiusTech grew its global footprint, acquired new clients and expanded services across healthcare analytics, interoperability, imaging, and value-based care support.
Under the prospective deal, CitiusTech’s enterprise valuation could reach US$ 2.2-2.4 billion, implying a robust exit multiple for EQT. The valuation reflects renewed interest in healthcare-tech outsourcing and consulting, especially as digital health investments rebound globally after a dip in technology budgets.
Other stakeholders including co-investor Bain Capital and the founders are expected to stay on; it’s unclear whether they plan to sell their share now or wait for further value appreciation.
The exit signals confidence in the long-term growth potential of global healthcare IT services, even amid macro-economic headwinds. Industry analysts note that demand for data-driven health-care solutions, interoperability, analytics and value-based-care infrastructure underpins such valuations.
“This exit reflects not just value creation at CitiusTech, but confidence in the future of digital health the stakes for data, analytics and connected care have never been higher.”
By
HB Team
